Skip to content
Top Menu
  • Subscribe Newsletter
  • 中文
GeneOnline News

GeneOnline News

The Next Generation Biotech Media

MENUMENU
  • Home
  • COVID-19
  • Topics
        • Asia Insight
        • Latest News
        • North America
        • International
  • Technology
  • Feature
  • Industry News
  • BIO Asia-Taiwan
  • Interview
  • Event
  • linkedin

Tag: Coronavirus

COVID-19 / Latest News

J&J’s Single-Shot Vaccine Becomes Third to Bag FDA’s Emergency Use Authorization

2021-02-27 - by Rajaneesh K. Gopinath - Leave a Comment

February 27th, 2021 – Just a day after the FDA advisory panel’s unanimous recommendation, the US Food and Drug Administration (USFDA) has issued an emergency use authorization (EUA) for Johnson …

Read More
COVID-19 / Latest News

Third COVID Vaccine on the Cards as FDA Panel Unanimously Recommends J&J’s Single Shot Candidate

2021-02-26 - by Daniel Ojeda - Leave a Comment

February 26th, 2021 – Johnson & Johnson has received endorsement from the Vaccines and Related Biological Products Advisory Committee (VRBPAC) for its single-shot COVID-19 vaccine, Ad26.COV2.S. The panel that convened …

Read More
COVID-19 / Latest News

FDA Staff Endorses J&J’s Single-Shot COVID Vaccine, Advisory Committee to Convene on Friday

2021-02-242021-02-24 - by Rajaneesh K. Gopinath - Leave a Comment

February 24th, 2021 – The US Food and Drug Administration (USFDA) staff has deemed Johnson & Johnson’s single-shot COVID-19 vaccine safe and effective. In a briefing document published on Wednesday morning, …

Read More
Asia Insight / COVID-19

COVID-19: Japan’s Fujifilm Holdings Restarts Clinical Trials of Repurposed Drug Avigan, Seeking Approval by October

2021-02-222021-02-22 - by Tyler Chen - Leave a Comment

Approved as an anti-flu drug in 2014 in Japan, Avigan (favipiravir) was repurposed by Japan’s Fujifilm Holdings Corp (Fujifilm) to treat COVID-19 patients in 2020. The drug is considered a …

Read More
Asia Insight / COVID-19

Japan Kicks off COVID-19 Inoculations with Pfizer-BioNTech Vaccine

2021-02-182021-02-18 - by Tyler Chen - Leave a Comment

On February 17, Japan launched the COVID-19 inoculation plan, prioritizing 40,000 frontline medical workers in 100 hospitals to be vaccinated with Pfizer/BioNTech’s COVID-19 vaccine that received the first emergency approval …

Read More
COVID-19 / North America

COVID-19: FDA Grants Emergency Use Authorization for Eli Lilly’s Antibody Combo Therapy

2021-02-10 - by T. Chakraborty - Leave a Comment

On February 9th, Eli Lilly announced receiving the FDA’s emergency use authorization for its COVID-19 combination therapy comprising bamlanivimab and etesevimab. The approval was based on data from the Phase …

Read More
South Africa puts Astra Zeneca vaccinations on hold
COVID-19 / Feature

South Africa Defers AstraZeneca Vaccinations as Vaccine Only Provides Minimal Protection against COVID-19 Variant

2021-02-09 - by Daniel Ojeda - Leave a Comment

On February 7th, the South African government decided to put the AstraZeneca vaccinations on hold after the COVID-19 vaccine was only 22% effective at preventing mild-to-moderate infections caused by the …

Read More
Asia Insight / COVID-19

COVID-19 News: Singapore, Korea, and China Accelerate Vaccine Approval, Indonesia Devises Detection Strategies

2021-02-05 - by Tyler Chen - Leave a Comment

Vaccine is one of the best weapons to tackle the COVID-19 pandemic, but it still needs a close examination of efficacy and safety to receive government approval. COVID-19 detection devices …

Read More
COVID-19 / International

Phase 3 Trial Results Grant New Validity to Controversial Sputnik V Vaccine

2021-02-04 - by Daniel Ojeda - Leave a Comment

On February 2nd, results from a Phase 3 clinical trial showed the Sputnik V vaccine, developed by the Gamaleya Institute in Moscow, was 91.6% effective against COVID-19. The vaccine was …

Read More
Clover Biopharmaceuticals chooses Dynavax over GSK for adjuvant
Asia Insight / COVID-19

Clover Biopharmaceuticals Chooses Dynavax over GSK for COVID-19 Vaccine Adjuvant

2021-02-03 - by Tyler Chen - Leave a Comment

China’s COVID-19 vaccine developer Clover Biopharmaceuticals has been testing two adjuvants, one from Dynavax and the other from GSK, on its vaccine in the early stages of trials. On February …

Read More

Posts navigation

1 2 … 16 Next

TODAY IN HISTORY

June 28, 2004: NHGRI Established Centers of Exellence in Genomic Science at Havard and Johns Hopkins University
Today In History
June 28, 2004: NHGRI Established Centers of Exellence in Genomic Science at Havard and Johns Hopkins University
2018-06-29
Tweets by GeneOnlineNews
  • Home
  • Feature
  • Technology
  • Industry News
  • Event
  • Topics
    • COVID-19
    • Asia Insight
    • International
    • Latest News
    • North America

MEDIA INQUIRIES

service@geneolineasia.com

website

Chinese
Copyright © 2021 GeneOnline News.
Powered by WordPress and HitMag.

[pie_register_login]